RESUMO
Os casos de transtorno de ansiedade têm apresentado crescimento considerável desde o início do século XX, onde a terapia medicamentosa oferecida, geralmente apresenta efeito sedativo, portanto, a busca por tratamentos adjuvantes para tratar quadros de ansiedade se fazem necessários. Estudos indicam que a modulação da microbiota intestinal pode estar relacionada à regulação neural dos indivíduos através de diversas vias, incluindo a aplicação de cepas probióticas e consumo de alimentos fermentados tradicionais como iogurte e kombucha, colaborando para a melhoria da qualidade de vida destes pacientes. Este projeto teve como objetivo buscar os metabólitos e neurotransmissores presentes no kombucha a fim de verificar seu potencial psicobióticos e comparar as aplicações e metabólitos produzidos por cepas probióticas existentes no mercado e em alimentos fermentados tradicionais que atuem no eixo intestino-cérebro. Foram realizadas pesquisas em bases de dados online, como Pubmed, Web of Science, Scielo, Scopus e Google Scholar no período entre 2002 e 2022 relacionados aos possíveis efeitos dos probióticos em condições de ansiedade, bem como como os mecanismos que envolvem o eixo cérebro-intestino, seja por meio de testes em humanos e em modelos animais. As espécies mais testadas quanto ao seu potencial probiótico e ação nos transtornos de ansiedade encontradas foram Lactobacillus paracasei, L. casei, L. rhamnosus, Bifidobacterium infanti e B. longum. Cada gênero demonstra um grau diferente na redução da ansiedade dos indivíduos. Os alimentos potencialmente probióticos, incluindo alimentos fermentados tradicionais, além de atuar como complemento à terapia em quadros de ansiedade, tem relevância no setor socioeconômico
Anxiety disorder cases have shown considerable growth since the beginning of the 20th century, where the drug therapy offered usually has a sedative effect. Therefore, the search for adjuvant treatments to treat anxiety disorders is necessary. Studies indicate that the modulation of the intestinal microbiota may be related to the neural regulation of individuals in several ways, including the application of probiotic strains and consumption of traditional fermented foods such as yogurt and kombucha, contributing to the improvement of the quality of life of these patients. This project aimed to identify and compare the psychobiotic effect in the gut-brain axis of the metabolites and neurotransmitters produced by kombucha and commercial probiotic strains. The research was carried out in online databases, such as Pubmed, Web of Science, Scielo, Scopus, and Google Scholar in the period between 2002 and 2022 related to the possible effects of probiotics in anxiety conditions as the mechanisms that involve the brain-gut axis either through tests in humans or animal models. The species most tested for their probiotic potential and action on anxiety disorders were Lactobacillus paracasei, L. casei, L. rhamnosus, Bifidobacterium infanti, and B. longum. Each genus demonstrates a different degree of reducing individuals' anxiety. Potentially probiotic foods, including traditional fermented foods, acting as a complement to therapy in cases of anxiety, have relevance in the socioeconomic sector
Assuntos
Transtornos Fóbicos/patologia , Chá de Kombucha/análise , Chá de Kombucha/efeitos adversos , Serotonina/análogos & derivados , Microbiota , Alimentos Fermentados/efeitos adversos , Eixo Encéfalo-IntestinoRESUMO
The review summarizes the data related to the potential of the real time fMRI biofeedback (the rt-fMRI), a novel technology implementing instructing patients to modify the neural activity in the certain brain regions related to the disordered function. The recent positive results were gained for a treatment of the post-stroke impairments, the Parkinson disease, the pain syndrome, the tinnitus, the alcohol and nicotine abuse, the major depression, and phobias of contamination and spiders. The intervention Was found to be less promising for schizophrenia and nearly ineffective for the criminal antisocial personality disorder. The reliability of the results is mostly poor due to suboptimal study designs, lack of the control groups, and insufficient sample sizes. The article deals with biological basis of the technology, its current applications and perspectives; and also its method- ologicdl and methodical problems.
Assuntos
Biorretroalimentação Psicológica/métodos , Transtorno Depressivo Maior/terapia , Neuralgia Facial/terapia , Imageamento por Ressonância Magnética/métodos , Doença de Parkinson/terapia , Transtornos Fóbicos/terapia , Acidente Vascular Cerebral/terapia , Zumbido/terapia , Alcoolismo/patologia , Alcoolismo/fisiopatologia , Alcoolismo/terapia , Biorretroalimentação Psicológica/instrumentação , Encéfalo/patologia , Encéfalo/fisiopatologia , Transtorno Depressivo Maior/patologia , Transtorno Depressivo Maior/fisiopatologia , Neuralgia Facial/patologia , Neuralgia Facial/fisiopatologia , Humanos , Imageamento por Ressonância Magnética/instrumentação , Doença de Parkinson/patologia , Doença de Parkinson/fisiopatologia , Transtornos Fóbicos/patologia , Transtornos Fóbicos/fisiopatologia , Reprodutibilidade dos Testes , Projetos de Pesquisa , Fumar/patologia , Fumar/fisiopatologia , Fumar/terapia , Acidente Vascular Cerebral/patologia , Acidente Vascular Cerebral/fisiopatologia , Zumbido/patologia , Zumbido/fisiopatologia , Resultado do TratamentoRESUMO
Little is known, so far, about the cerebral structural deficits in drug-naïve adult social anxiety disorder (SAD) patients. The present study aimed to explore the cerebral anatomic deficits in drug-naïve adult generalized SAD patients using voxel-based morphometric analysis with DARTEL. High-resolution T1-weighted images were acquired from 20 drug-naïve adult SAD patients and 19 age-, sex- and education-matched controls. The volumes of gray matter, white matter, cerebrospinal fluid, and total intracranial volume were compared between groups using two-sample t-tests with age and gender as covariates. Gray matter density (GMD) was compared between groups using voxel-wise two-sample t-test analysis. Correlation analysis was used to identify any associations between regional GMD and clinical symptoms. Compared with healthy controls, SAD patients showed significantly lower GMD in the bilateral thalami, right amygdala, and right precuneus. Furthermore, the GMD in the right amygdala was negatively related to the disease duration, but positively correlated with age of onset. Our findings demonstrated that cerebral anatomic deficits could be found within limbic and thalamic areas in drug-naïve SAD patients, which provides structural information to complement the functional alterations observed in the same regions.
Assuntos
Encéfalo/patologia , Fibras Nervosas Mielinizadas/patologia , Fibras Nervosas Amielínicas/patologia , Transtornos Fóbicos/patologia , Adolescente , Adulto , Tonsila do Cerebelo/patologia , Feminino , Humanos , Processamento de Imagem Assistida por Computador , Imageamento por Ressonância Magnética , Masculino , Tálamo/patologiaRESUMO
The propensity to develop an anxiety disorder is thought to be determined by genetic and environmental factors. Here we investigated the relationship between a genetic predisposition to trait anxiety and experience-based learned fear in a psychopathological mouse model. Male CD-1 mice selectively bred for either high (HAB), or normal (NAB) anxiety-related behaviour on the elevated plus maze were subjected to classical fear conditioning. During conditioning both mouse lines showed increased fear responses as assessed by freezing behaviour. However, 24 h later, HAB mice displayed more pronounced conditioned responses to both a contextual or cued stimulus when compared with NAB mice. Interestingly, 6 h and already 1 h after fear conditioning, freezing levels were high in HAB mice but not in NAB mice. These results suggest that trait anxiety determines stronger fear memory and/or a weaker ability to inhibit fear responses in the HAB line. The enhanced fear response of HAB mice was attenuated by treatment with either the α(2,3,5)-subunit selective benzodiazepine partial agonist L-838,417, corticosterone or the selective neurokinin-1 receptor antagonist L-822,429. Overall, the HAB mouse line may represent an interesting model (i) for identifying biological factors underlying misguided conditioned fear responses and (ii) for studying novel anxiolytic pharmacotherapies for patients with fear-associated disorders, including post-traumatic stress disorder and phobias.
Assuntos
Ansiolíticos/uso terapêutico , Transtornos de Ansiedade/tratamento farmacológico , Transtornos de Ansiedade/patologia , Modelos Animais de Doenças , Medo/fisiologia , Camundongos , Animais , Transtornos de Ansiedade/complicações , Transtornos de Ansiedade/psicologia , Comportamento Animal , Corticosterona/uso terapêutico , Progressão da Doença , Avaliação Pré-Clínica de Medicamentos , Emoções Manifestas/fisiologia , Fluorbenzenos/uso terapêutico , Masculino , Antagonistas dos Receptores de Neurocinina-1 , Transtornos Fóbicos/complicações , Transtornos Fóbicos/tratamento farmacológico , Transtornos Fóbicos/patologia , Condicionamento Físico Animal/fisiologia , Condicionamento Físico Animal/psicologia , Piperidinas/uso terapêutico , Psicopatologia , Triazóis/uso terapêutico , Regulação para CimaRESUMO
Sintomas ansiosos são extremamente frequentes na prática médica. O diagnóstico de um transtorno ansioso depende da intensidade e duração dos sintomas, assim como de sua conexão com estímulos ambientais. Os critérios diagnósticos atuais discriminam vários tipos de transtornos ansiosos de forma que a comorbidade entre eles é frequentemente encontrada. Este artigo revê o quadro clínico e as estratégias gerais de tratamento farmacológico e psicoterapêutico do transtorno de pânico, agorafobia, transtorno de ansiedade generalizada, fobia social, fobias específicas, transtorno de estresse pós-traumático e transtorno obsessivo-compulsivo.
Assuntos
Humanos , Masculino , Feminino , Transtorno de Pânico/patologia , Transtornos Fóbicos/patologia , Transtornos de Ansiedade/diagnóstico , Transtornos de Ansiedade/terapia , Medicina PsicossomáticaRESUMO
Individuals with social phobia display neural hyperactivation towards angry facial expressions. However, it is uncertain whether they also show abnormal brain responses when processing angry voices. In an event-related functional magnetic resonance imaging study, we investigated brain responses to neutral and angry voices in 12 healthy control participants and 12 individuals with social phobia when emotional prosody was either task-relevant or task-irrelevant. Regardless of task, both phobic and non-phobic participants recruited a network comprising frontotemporal regions, the amygdala, the insula, and the striatum, when listening to angry compared to neutral prosody. Across participants, increased activation in orbitofrontal cortex during task-relevant as compared to task-irrelevant emotional prosody processing was found. Compared to healthy controls, individuals with social phobia displayed significantly stronger orbitofrontal activation in response to angry versus neutral voices under both task conditions. These results suggest a disorder-associated increased involvement of the orbitofrontal cortex in response to threatening voices in social phobia.